Drug purchases through retail pharmacies in the world's leading 10 markets rose 8% in the first 11 months of 1995 to $125.68 million, reports IMS International.
The fastest-growing country was Spain, rising 11% to $4.35 billion, then the USA, up 10% to $48.90 billion, and Japan and the UK, rising 9% to $24.01 billion and $5.70 billion respectively. By therapeutic category, the largest increase was for respiratory products, up 13% to $12.62 billion, followed by central nervous system drugs, anti-infectives and blood agents, all up 12% to $16.24 billion, $13.08 billion and $7.07 billion respectively.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze